Literature DB >> 32580706

Prognostic role of the preoperative neutrophil-to-lymphocyte ratio and albumin for 30-day mortality in patients with postoperative acute pulmonary embolism.

Chuan Liu1,2, Hui-Lu Zhan1,3, Zhang-Heng Huang1, Chuan Hu4, Yue-Xin Tong1, Zhi-Yi Fan1, Meng-Ying Zheng5, Cheng-Liang Zhao6, Gui-Yun Ma7.   

Abstract

BACKGROUND: This retrospective study aimed to investigate the prognostic value of the neutrophil-to-lymphocyte ratio (NLR) and albumin for 30-day mortality in patients with postoperative acute pulmonary embolism (PAPE).
METHODS: We retrospectively reviewed the medical records of 101 patients with PAPE admitted from September 1, 2012, to March 31, 2019. The characteristics, surgical information, admission examination data and mortality within 30 days after PAPE were obtained from our electronic medical recording system and follow-up. The associations between the NLR, PLR, and other predictors and 30-day mortality were analyzed with univariate and multivariate analyses. Then, the nomogram including the independent predictors was established and evaluated.
RESULTS: Twenty-four patients died within 30 days, corresponding to a 30-day mortality rate of 23.8%. The results of the multivariate analysis indicated that both the NLR and albumin were independent predictors for 30-day mortality in patients with PAPE. The probability of death increased by approximately 17.1% (OR = 1.171, 95% CI: 1.073-1.277, P = 0.000) with a one-unit increase in the NLR, and the probability of death decreased by approximately 15.4% (OR = 0.846, 95% CI: 0.762c-0.939, P = 0.002) with a one-unit increase in albumin. The area under the curve of the nomogram was 0.888 (95% CI: 0.812-0.964).
CONCLUSION: Our findings showed that an elevated NLR and decreased albumin were related to poor prognosis in patients with PAPE. The NLR and albumin were independent prognostic factors for PAPE.

Entities:  

Keywords:  Albumin; Mortality; Neutrophil-to-lymphocyte ratio; Postoperative acute pulmonary embolism

Mesh:

Substances:

Year:  2020        PMID: 32580706      PMCID: PMC7315518          DOI: 10.1186/s12890-020-01216-5

Source DB:  PubMed          Journal:  BMC Pulm Med        ISSN: 1471-2466            Impact factor:   3.317


  33 in total

Review 1.  Contact system revisited: an interface between inflammation, coagulation, and innate immunity.

Authors:  A T Long; E Kenne; R Jung; T A Fuchs; T Renné
Journal:  J Thromb Haemost       Date:  2016-02-09       Impact factor: 5.824

Review 2.  Recent insights into the role of the contact pathway in thrombo-inflammatory disorders.

Authors:  Maurits L van Montfoort; Joost C M Meijers
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2014-11-18

3.  Predictive value of serum Hs-CRP levels for outcomes of pulmonary embolism.

Authors:  Omer Araz; Elif Yilmazel Ucar; Aslıhan Yalcin; Nazli Kelercioglu; Mehmet Meral; Ali Metin Gorguner; Metin Akgun
Journal:  Clin Respir J       Date:  2014-09-03       Impact factor: 2.570

4.  Prevalence and Risk Factors of Acute Pulmonary Embolism in Patients with Lung Cancer Surgery.

Authors:  Yu-Ping Li; Lei Shen; Wei Huang; Xue-Fei Hu; Dong Xie; Jian Yang; Xiao Song; Yan-Feng Zhao; Chao-Jie Zhou; Ge-Ning Jiang
Journal:  Semin Thromb Hemost       Date:  2018-01-10       Impact factor: 4.180

Review 5.  Clinical indications for the albumin use: still a controversial issue.

Authors:  Paolo Caraceni; Marco Domenicali; Alessandra Tovoli; Lucia Napoli; Carmen Serena Ricci; Manuel Tufoni; Mauro Bernardi
Journal:  Eur J Intern Med       Date:  2013-06-20       Impact factor: 4.487

Review 6.  Human serum albumin: from bench to bedside.

Authors:  Gabriella Fanali; Alessandra di Masi; Viviana Trezza; Maria Marino; Mauro Fasano; Paolo Ascenzi
Journal:  Mol Aspects Med       Date:  2011-12-30

7.  Pretreatment neutrophil/lymphocyte ratio is superior to platelet/lymphocyte ratio as a predictor of long-term mortality in breast cancer patients.

Authors:  Basem Azab; Neeraj Shah; Jared Radbel; Pamela Tan; Vijaya Bhatt; Steven Vonfrolio; Ayman Habeshy; Antonio Picon; Scott Bloom
Journal:  Med Oncol       Date:  2013-01-03       Impact factor: 3.064

8.  Neutrophil-to-lymphocyte ratio for the assessment of hospital mortality in patients with acute pulmonary embolism.

Authors:  Korhan Soylu; Ömer Gedikli; Alay Ekşi; Yonca Avcıoğlu; Ayşegül İdil Soylu; Serkan Yüksel; Okan Gülel; Özcan Yılmaz
Journal:  Arch Med Sci       Date:  2016-02-02       Impact factor: 3.318

9.  Neutrophil-to-Lymphocyte Ratio Is an Independent Predictor of 30-Day Mortality of Intracerebral Hemorrhage Patients: a Validation Cohort Study.

Authors:  Fei Wang; Li Wang; Ting-Ting Jiang; Jian-Jun Xia; Feng Xu; Li-Juan Shen; Wen-Hui Kang; Yong Ding; Li-Xia Mei; Xue-Feng Ju; Shan-You Hu; Xiao Wu
Journal:  Neurotox Res       Date:  2018-03-28       Impact factor: 3.911

10.  The values of neutrophil to lymphocyte ratio and platelet to lymphocyte ratio in predicting 30 day mortality in patients with acute pulmonary embolism.

Authors:  Yaqing Ma; Yimin Mao; Xuegai He; Yuxia Sun; Shenshen Huang; Jiayong Qiu
Journal:  BMC Cardiovasc Disord       Date:  2016-06-04       Impact factor: 2.298

View more
  4 in total

1.  A Prediction Model Based on Blood Biomarker for Mortality Risk in Patients with Acute Venous Thromboembolism.

Authors:  Jianjun Jiang; Junshuai Xue; Yang Liu
Journal:  J Inflamm Res       Date:  2022-08-18

2.  Diagnostic accuracy of adropin as a preliminary test to exclude acute pulmonary embolism: a prospective study.

Authors:  Serhat Orun; Aliye Celikkol; Batuhan Ilbey Basol; Elif Yeniay
Journal:  BMC Pulm Med       Date:  2022-09-18       Impact factor: 3.320

3.  The Association of Neutrophil-Lymphocyte Ratio with Venous Thromboembolism: A Systematic Review and Meta-Analysis.

Authors:  Jingjing Hu; Zhaobin Cai; Yidan Zhou
Journal:  Clin Appl Thromb Hemost       Date:  2022 Jan-Dec       Impact factor: 3.512

4.  Development and validation of a novel risk assessment model to estimate the probability of pulmonary embolism in postoperative patients.

Authors:  Mao-Feng Wang; Fei-Xiang Li; Lan-Fang Feng; Chao-Nan Zhu; Shuang-Yan Fang; Cai-Min Su; Qiong-Fang Yang; Qiao-Ying Ji; Wei-Min Li
Journal:  Sci Rep       Date:  2021-09-10       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.